Ledger.Open graph →
SEC Form D · filed July 14, 2022

Areteia Therapeutics, Inc

Offering
$350.0M
Sold
$175.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SHORT HILLS, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Jorge E. Bartolome · Short Hills, NJDirectorBenjamin Gomez · Short Hills, NJDirectorIan Read · Short Hills, NJDirectorPaul Berns · Short Hills, NJDirectorMichael E. Bozik · Pittsburggh, PADirectorChris E. Visioli · Short Hills, NJExecStephen E. Butts · Smithfield, NCDirectorAdam Koppel · Boston, MADirectorChristopher T. Cox · Short Hills, NJExecWhit E. Bernard · Short Hills, NJExecJorge E. Bartolome · Short Hills, NJDirectorChris E. Visioli · Short Hills, NJExecStephen E. Butts · Morrisville, NCDirectorBenjamin Gomez · Short Hills, NJDirectorAdam Koppel · Cambridge, MADirectorIan Read · Short Hills, NJDirectorPaul Berns · Short Hills, NJDirectorChristopher T. Cox · Short Hills, NJExecWhit E. Bernard · Short Hills, NJExecMichael E. Bozik · Pittsburggh, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗